Product Categories
Country: | China |
---|---|
Tel: | 0316-2883536 |
Mobile: | 19333636468 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
N-[(2R)-3-[[3-Fluoro-4-(4-morpholinyl)phenyl]amino]-2-hydroxypropyl]acetamide | C15H22FN3O3 | 333753-67-6 | Details |
N-[[(5S)-3-[4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]Methyl]acetaMide | C16H21N3O4 | 556801-15-1 | Details |
Linezolid Impurity 12 | C20H28FN3O4 | 1215006-11-3 | Details |
(S)-N-(3-Chloro-2-hydroxypropyl)acetamide | C5H10ClNO2 | 224323-47-1 | Details |
Linezolid Impurity (N,O-Desethylene Linezolid) | C14H18FN3O4 | 1219708-30-1 | Details |
benzyl 3-fluoro-4-(4-morpholinyl)phenylcarbamate | C18H19FN2O3 | 1027135-00-7 | Details |
(S)-5-((Tert-butylamino)methyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one | C18H26FN3O3 | 1215006-08-8 | Details |
Linezolid Related Compound B | C16H20FN3O3S | 216868-57-4 | Details |
(5S,5'S)-5,5'-(azanediylbis(methylene))bis(3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one) | C28H33F2N5O6 | 2307625-63-2 | Details |
21-Acetoxy-16α,17-isopropylidendioxy-pregna-1,4-dien-3,11,20-trion | C26H32O7 | 3754-07-2 | Details |
(S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one | C14H18FN3O3 | 168828-90-8 | Details |
N-benzyloxycarbonyl-3-fluoro-4-morpholinoaniline | C18H19FN2O3 | 168828-81-7 | Details |
OPEN RING AZTREONAM | C13H19N5O9S2 | 87500-74-1 | Details |
Aztreonam Impurity B | C13H19N5O6S | 102586-36-7 | Details |
Desulfo Aztreonam | C13H17N5O5S | 102579-59-9 | Details |
Desacetyl-N,O-descarbonyl Linezolid | C13H20FN3O2 | 333753-72-3 | Details |
Linezolid N-Oxide | C16H20FN3O5 | 189038-36-6 | Details |
Aztreonam ethyl ester | C15H21N5O8S2 | 102579-57-7 | Details |
(R)-1-Boc-3-Aminopiperidine | C10H20N2O2 | 188111-79-7 | Details |
Bis-Linezolid | C30H35F2N5O7 | 908143-04-4 | Details |
R-Linezolid | C16H20FN3O4 | 872992-20-6 | Details |
Desonide Impurity 7 | C23H30O6 | 117782-94-2 | Details |
Desisobutyryl Ciclesonide | C28H38O6 | 161115-59-9 | Details |
Desonide delta-9(11) Analog | C24H30O5 | 5541-37-7 | Details |
Olmesartan Medoxomil Impurity G | C43H38N6O2 | 761404-82-4 | Details |
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate | C15H20N2O6 | 144978-05-2 | Details |
Olmesartan Medoxomil Impurity 26 | C34H34N6O9 | 1392475-91-0 | Details |
Dehydro Olmesartan | C24H24N6O2 | 172875-98-8 | Details |
Olmesartan Impurity 51 | C45H46N6O2 | 1418133-29-5 | Details |
OlMesartan DiMer Ester IMpurity | C48H50N12O5 | 1040250-19-8 | Details |
1H-Imidazole-4,5-dicarboxylic acid, 2-propyl-1-[[2'-[1-(triphenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]- | C41H34N6O4 | 1350442-05-5 | Details |
Olmesartan Impurity 9 | C10H14N2O2 | 849206-42-4 | Details |
Olmesartan Impurity 8 | C12H18N2O2 | 157356-73-5 | Details |
Olmesartan Medoxomil Impurity O | C45H44N6O3 | 189400-21-3 | Details |
Olmesartan Medoxomil Impurity 7 | C43H40N6O3 | 761404-85-7 | Details |
Olmesartan Medoxomil Impurity 17 | C53H54N12O8 | 1418133-31-9 | Details |
Trityl olmesartan | C48H44N6O6 | 144690-92-6 | Details |
Olmesartan Impurity G | C33H24Br2N4 | 358685-13-9 | Details |
Olmesartan Impurity 89 | C33H24Br2N4 | 151052-34-5 | Details |
Valsartan Impurity | C33H25BrN4 | 1894176-40-9 | Details |
2'-(1H-Tetrazol-5-yl)-1,1'-biphenyl-4-carboxaldehyde (Losartan IMpurity) | C14H10N4O | 151052-40-3 | Details |
Olmesartan Medoxomil Impurity 28 | C14H10Br2N4 | 1127249-17-5 | Details |
5-[4'-(Bromomethyl)-[1,1'-biphenyl]-2-yl]-2-(triphenylmethyl)-2H-tetrazole | C33H25BrN4 | 133051-88-4 | Details |
Prasugrel EP Impurity C | C20H20FNO3S | 1391194-50-5 | Details |
Prasugrel Impurity I | C20H21NO3S | 1391194-45-8 | Details |
Prasugrel EP Impurity E | C20H21ClFNO3S | 1056459-37-0 | Details |
Loteprednol Impurity | C24H30Cl2O7 | 207670-58-4 | Details |
1-Cyclopropyl-2-(2-fluorophenyl)ethane-1,2-dione | C11H9FO2 | 1391054-37-7 | Details |
Olmesartan Impurity 65 | C13H22N2O3 | 172875-53-5 | Details |
OlMesartan interMediate iMpurity II | C11H16N2O3 | 144690-07-3 | Details |
Olmesartan Impurity 1 | C11H18N2O2 | 2411637-68-6 | Details |
Irbesartan Impurity 3 | C14H11N7 | 152708-24-2 | Details |
Irbesartan Impurity 14 | C25H28N6O | 133690-91-2 | Details |
5-(4'-Methylbiphenyl-2-yl)-1-trityl-1H-tetrazole | C33H26N4 | 124750-53-4 | Details |
Olmesartan Medoxomil Impurity 32 | C49H46N6O6 | 1040405-56-8 | Details |
Olmesartan | C24H26N6O3 | 144689-24-7 | Details |
Olmesartan Impurity 52 | C8H10N2O4 | 58954-23-7 | Details |
diethyl 2-propylimidazoledicarbonate | C12H18N2O4 | 144689-94-1 | Details |
Olmesartan Medoxomil Impurity E | C26H30N6O3 | 144689-23-6 | Details |
(2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol | C33H26N4O | 154709-18-9 | Details |
diethyl 2-propyl-1-((2'-(1-trityl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-imidazole-4,5-dicarboxylate | C45H42N6O4 | 144690-53-9 | Details |
2'-(Triphenylmethyltetrazol-5-yl)biphenyl-4-yl]carboxaldehyde;Olmesartan Impurity 81 | C33H24N4O | 155983-56-5 | Details |
Losartan EP Impurity B | C14H12N4O | 160514-13-6 | Details |
Loteprednol Impurity | C24H29Cl3O6 | 207670-57-3 | Details |
Prasugrel Impurity II | C20H20FNO3S | 1391194-39-0 | Details |
Prasugrel Hydroxy Thiolactone | C18H18FNO3S | 947502-66-1 | Details |
Olmesartan Medoxomil Impurity 25;2-propyl-1H-imidazole-4,5-dicarboxylic acid | C10H16N2O3 | 144690-04-0 | Details |
Cholic Acid Ethyl Este | C26H44O5 | 47676-48-2 | Details |
(4-ETHOXY-2-OXO-2,5-DIHYDRO-PYRROL-1-YL)-ACETIC ACID | C8H11NO4 | 142274-08-6 | Details |
Fluticasone propionate Impurity K | C25H31F3O6 | 1174034-79-7 | Details |
Prednisone Impurity K | C19H22O3 | 7738-93-4 | Details |
Hydrocortisone Acetate EP impurity G | C25H34O7 | 81968-66-3 | Details |
5-Pyrimidinecarboxamide, 4-[[(3-chlorophenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)- | C22H24ClN7O2 | 330786-28-2 | Details |
VWLTWMGSJXSKQJ-ROXMPKABSA-N | C25H32O7 | 17652-24-3 | Details |
1β-Hydroxy-6α-Methyl-1,4-androstadiene-3,17-dione | C20H26O3 | 61919-52-6 | Details |
dithiodesethylcarbodenafil | C22H28N6OS2 | 1610830-81-3 | Details |
Sildenafil Impurity IV-1 | C13H18N2O5S | 1308332-48-0 | Details |
Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-21-methoxy-16-methyl-, (11β,16α)- | C23H31FO5 | 114546-86-0 | Details |
17β-Carboxy-17-desoxy Dexamethasone | C21H27FO4 | 75262-69-0 | Details |
Prednicarbate EP Impurity E | C26H34O8 | 671225-23-3 | Details |
17β-Carboxy-17α-formyloxy Dexamethasone | C22H27FO6 | 473273-04-0 | Details |
Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-9,11-epoxy-17-hydroxy-16-methyl-, (11α,16α)- | C24H30O6 | 14622-51-6 | Details |
Loteprednol Impurity 31 | C23H29ClO7 | 265651-89-6 | Details |
diethyl 2,2'-(4-isobutoxy-1,3-phenylene)bis(4-methylthiazole-5- carboxylate) | C24H28N2O5S2 | 1346238-13-8 | Details |
ethyl 2-(2-hydroxyphenyl)-4-methylthiazole-5-carboxylate | C13H13NO3S | 118485-48-6 | Details |
ethyl 2-(5-cyano-2-isobutoxyphenyl)-4-methylthiazole-5- carboxylate | C11H10N2O | 1229019-33-3 | Details |
Febuxostat Impurity 40 | C18H22N2O4S | 1271738-74-9 | Details |
Febuxostat | C16H16N2O3S | 144060-53-7 | Details |
Febuxostat Impurity 55 | C17H18N2O3S | 144060-84-4 | Details |
Febuxostat Impurity 6 | C17H21NO3S | 144060-97-9 | Details |
Febuxostat Impurity 33 | C12H14O5 | 100118-38-5 | Details |
Febuxostat Impurity 111 | C7H7NOS | 104317-54-6 | Details |
Oseltamivir Impurity 30 | Details |
Benzoic acid, 2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]-, hydrochloride, compd. with N,N-diethylethanamine (1:1:1) | C20H35N3O5S | 215299-33-5 | Details |
Irbesartan Impurity 24 | C14H12N4O | 2763750-28-1 | Details |
Olmesartan Impurity 19 | C14H11ClN4 | 161952-66-5 | Details |
N-methyl-O-desethyl vardenafil | C20H26N6O4S | 2762747-27-1 | Details |
4'-(azidomethyl)-[1,1'-biphenyl]-2-carboxylic acid | C14H11N3O2 | 2758005-15-9 | Details |
4'-(Dibromomethyl)-[1,1'-Biphenyl]-2-Carbonitrile | C14H9Br2N | 209911-63-7 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |